Editas Medicine, Inc. (NASDAQ:EDIT) Short Interest Update
Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) was the target of a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 18,210,000 shares, a growth of 7.6% from the December 15th total of 16,930,000 shares. Based on an average daily volume of 2,620,000 shares, […]
More Stories
Judge Issues Order to Keep Intelligence Employees on Administrative Leave
By Sam Dorman ALEXANDRIA, Va.—A federal judge ordered the Trump administration on March 31 to keep a group of intelligence...
Why Eggs Are Cheaper in Mexico and Canada
By Austin Alonzo While all three of the largest countries in North America are dealing with outbreaks of highly pathogenic...
Kefir: Better Than Probiotic Supplements With Broad Immune System Support
By Zena le Roux Kefir may not be the first thing that comes to mind when looking to boost your...
US Treasury Targets Hezbollah’s Iran-Backed Aid Network
By Naveen Athrappully Individuals and entities helping to finance the Hezbollah terrorist group were sanctioned by the Department of the...
Kremlin Says US and Russian Companies Interested in Rare Earths Partnership but Challenges Remain
By Ryan Morgan Several Russian and U.S. companies have shown an interest in new joint ventures focused on rare earth...
Corebridge Financial Inc. Sells 202 Shares of Datadog, Inc. (NASDAQ:DDOG)
Corebridge Financial Inc. lessened its position in Datadog, Inc. (NASDAQ:DDOG – Free Report) by 0.8% during the fourth quarter, according...